News Release

July 18, 2014

Contact: Chris DeFrancesco, 860-679-3914
Email: cdefrancesco@uchc.edu

Dermatologist, Mohs Surgeon Joins UConn Health

FARMINGTON, CONN. Dr. Nicole Cote, a dermatologist with proficiency in Mohs micrographic surgery, is now seeing patients at UConn Health in Farmington and Southington.

Cote brings her expertise in general dermatology and advanced, precise treatment of skin cancer to UConn Health from the Mayo Clinic Health System in Wisconsin, where she established a Mohs surgery program. Mohs surgery is considered the gold standard in removing cancerous cells while sparing healthy skin tissue.

Cote is fellowship trained in dermatopathology from the University of Virginia and procedural dermatology from the Virginia Commonwealth University Health System, where she also completed a dermatology residency. Her medical degree is from the Duke University School of Medicine. She is board certified in dermatology and dermatopatholgy.

Cote is a resident of West Hartford.

To schedule an appointment, call 860-679-7546. More information about the UConn Health Department of Dermatology is available at dermatology.uchc.edu.

High-resolution photo: http://today.uchc.edu/images/news/cote.jpg
Caption: Dr. Nicole Cote, general dermatologist and Mohs surgeon, is seeing patients at UConn Health in Farmington and Southington.

UConn Health includes the schools of medicine and dental medicine, the UConn Medical Group, University Dentists, and John Dempsey Hospital. Home to Bioscience Connecticut, UConn Health pursues a mission of providing outstanding health care education in an environment of exemplary patient care, research and public service. More information about UConn Health is available at www.uchc.edu.

Note: News professionals are invited to visit the UConn Health Today news page (http://today.uchc.edu) for regularly updated news and feature stories, photos and media stories. News releases are archived at http://today.uchc.edu/newsreleases/2014. UConn Health news and information is also available on Facebook, Twitter and YouTube.